MedPath

To see the efficacy of the new therapy named Cognitive-Coping Therapy and also studying its Neurological Impact on the brains of patients with Obsessive-Compulsive Disorder

Phase 1
Conditions
Health Condition 1: G- Mental Health
Registration Number
CTRI/2023/06/054545
Lead Sponsor
Central Institute of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients scoring at least moderate severity (more than 16) on Y â?? BOCS.

Those who have given informed consent

Exclusion Criteria

Patients with a history of major neurological illness.

Patients who have received ECT in the last 6 months.

Co-morbid psychosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath